眼科領域におけるCefotiam hexetilの臨床的研究

DOI

書誌事項

タイトル別名
  • CEFOTIAM HEXETIL IN OPHTHALMOLOGY

抄録

Cefotiam hexetil (CTM-HE) a new oral cephalosporin antibiotic, was administered to a total of 42 patients, namely 18 patients with hordeolum, 15 with meibomitis, 2 with corneal ulcer, 1 with corneal infiltration and 6 with dacryocystitis, to evaluate its clinical efficacy. CTM-HE was given at 100mg or 200mg three times a day after meals, and the duration of administration ranged from 3-35days. The clinical efficacy was excellent in 10 patients, good in 30 and fair in 2, the efficacy rate being 95.2%. There were no side effects.

収録刊行物

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ